Order Article Reprints

Pons-Faudoa FP, Trani ND, Sizovs A, Shelton KA, Momin Z, Bushman LR, Xu J, Lewis DE, Demaria S, Hawkins T, et al. Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant. Pharmaceutics. 2020; 12(10):981. https://doi.org/10.3390/pharmaceutics12100981

Pons-Faudoa, Fernanda P., Nicola Di Trani, Antons Sizovs, Kathryn A. Shelton, Zoha Momin, Lane R. Bushman, Jiaqiong Xu, Dorothy E. Lewis, Sandra Demaria, Trevor Hawkins, and et al. 2020. "Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant" Pharmaceutics 12, no. 10: 981. https://doi.org/10.3390/pharmaceutics12100981

Pons-Faudoa, F. P., Trani, N. D., Sizovs, A., Shelton, K. A., Momin, Z., Bushman, L. R., Xu, J., Lewis, D. E., Demaria, S., Hawkins, T., Rooney, J. F., Marzinke, M. A., Kimata, J. T., Anderson, P. L., Nehete, P. N., Arduino, R. C., Sastry, K. J., & Grattoni, A. (2020). Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant. Pharmaceutics, 12(10), 981. https://doi.org/10.3390/pharmaceutics12100981